Press Announcements > FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

Press Announcements > FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy.
The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft tissue deformities. A patient uses a dose controller to independently inflate the expander.

Read the News Release